Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: An Interim CEO at Vermillion and More

Premium

Vermillion has named Bruce Huebner interim CEO, taking over for Gail Page, who will serve as a strategic advisor to the company. The company’s board has formed a succession committee and retained an executive search firm to find a new CEO to fill the post long-term.

Huebner will continue to serve on the company’s board of directors. His executive management experience includes stints as president of Osmetech, president and CEO of Nanogen, and executive vice president and chief operating officer at Gen-Probe.


CombiMatrix has appointed Jeremy Jones to its board of directors.

Jones is currently chairman of healthcare staffing firm On Assignment as well as a member of the advisory board of MedidaMetrics. Previously he served as chairman of the Health Industry Distributors Association and on the board of the National Association of Medical Equipment Services.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.